Topsham Open House
Chemotherapy Safety in Bangladesh
Day Four In Bangladesh
Breast Cancer Mission in Bangladesh
The Future of Cancer Research
Our Director of Clinical Research, Dr. Christian Thomas, sees quality, personal medicine, and immunotherapy as three key areas of promise, innovation, and change.
Enhanced Quality
In July 2016, NECS was selected to participate in the oncology care model (OCM), a new government-sponsored quality program for cancer care. Practices participating in this model will provide additional quality information such as screening for depression and pain, advanced directive planning, and how to best provide…
Roy's Story
Roy remembers the day he was diagnosed with advanced lung cancer. He was told that he had about a year and a half or two years, and so he started getting his affairs in order.
That was five years ago.
After beginning standard chemotherapy treatment at New England Cancer Specialists in July of 2012, Roy experienced some of the common side effects, such as nausea. But the treatment only slowed the progress of his disease. It did not reduce the size of his tumor, or stop the progression of his…
Research Month - Our History of Innovation
New England Cancer Specialists has a long and rich experience of participating in oncology clinical trials here in Maine. The research program began in 1982 when NECS, then known as the Maine Center for Cancer Medicine, began participating in grant funded research studies. Not long after, in 1988, NECS participated in our first National Cancer Institute (NCI) cooperative group study, with one of the Maine Center for Cancer Medicine’s first physicians, Dr. Delvin Case, as the principal…